Elanco Animal Health Inc (ELAN)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
In fiscal 2025, Elanco Animal Health Inc reported revenue of $4.71B, up 6.2% from the prior year. The company ran a net loss, with a net margin of -4.9% and a gross margin of 55.0%. It held $13.36B in total assets against $6.81B in total liabilities.
Key ratios (FY2025)
55.0%
Gross margin
-4.9%
Net margin
-3.5%
Return on equity
+6.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | $2.89B | $2.91B |
| Cost of Revenue | $2.12B | $2.00B | $1.93B | $1.91B | $2.13B | $1.67B | $1.47B | $1.57B | $1.49B | $1.41B |
| Gross Profit | $2.59B | $2.44B | $2.49B | — | — | — | — | — | — | — |
| Net Income | -$232.00M | $338.00M | -$1.23B | -$78.00M | -$483.00M | -$574.00M | $68.00M | $86.50M | -$310.70M | -$47.90M |
| EPS (Diluted) | $-0.47 | $0.68 | $-2.50 | $-0.16 | $-0.99 | $-1.30 | $0.18 | $0.28 | $-1.06 | — |
| Total Assets | $13.36B | $12.61B | $14.36B | $15.49B | $16.48B | $17.69B | $8.99B | $8.96B | $8.94B | — |
| Total Liabilities | $6.81B | $6.52B | $8.14B | $8.20B | $8.97B | $9.22B | $3.44B | $3.76B | $1.16B | — |
| Shareholders' Equity | $6.55B | $6.10B | $6.22B | $7.29B | $7.51B | $8.46B | $5.54B | $5.20B | $7.78B | $7.02B |
| Cash & Equivalents | $545.00M | $468.00M | $352.00M | $345.00M | $638.00M | $495.00M | $334.00M | $474.80M | $323.40M | — |
| Operating Cash Flow | $560.00M | $541.00M | $271.00M | $452.00M | $483.00M | -$41.00M | $224.00M | $487.30M | $173.80M | $155.90M |
| Capital Expenditures | $276.00M | $147.00M | $140.00M | $171.00M | $159.00M | $135.00M | $140.00M | $134.50M | $98.60M | $110.30M |
| Shares Outstanding | 496.40M | 497.30M | 492.30M | 488.30M | 487.20M | 441.40M | 370.30M | 313.70M | 293.30M | — |